financetom
Business
financetom
/
Business
/
Alamos divests Turkish unit in $470 million deal, ending $1 billion legal dispute
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alamos divests Turkish unit in $470 million deal, ending $1 billion legal dispute
Sep 15, 2025 1:50 AM

Sept 15 (Reuters) - Canadian miner Alamos Gold ( AGI )

said late Sunday that it will sell its Turkish subsidiary for

$470 million to a Middle East-based mining company, ending a

years-long $1 billion legal battle.

Alamos will sell the Turkish unit to Tumad Madencilik

Sanayi, a mining company operated by conglomerate Nurol Holding.

As part of the deal, Alamos said arbitration proceedings

that its Netherlands units filed in 2021 against Turkey will

remain suspended, and shall be discontinued after certain

contractual milestones are reached.

Alamos has had an active presence in Turkey since 2010,

according to its website. In 2019, the miner had halted

construction work at its Kirazli project in western Turkey after

the mining concessions expired and amid protests against the

project. This led to the firm filing a $1 billion claim against

Turkey for "unfair and inequitable treatment" on the project.

The deal is expected to close in the fourth quarter of 2025,

Alamos said, adding that it will use the funds it receives to

reduce existing debt obligations and support the projects it is

developing.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech to Present Clinical Data Updates on Cancer Vaccine Candidates
BioNTech to Present Clinical Data Updates on Cancer Vaccine Candidates
Mar 11, 2024
02:03 PM EDT, 03/11/2024 (MT Newswires) -- BioNTech (BNTX) said Monday it will present clinical data updates on select investigational cancer vaccines from its pipeline at the annual meeting of the American Association for Cancer Research in San Diego, California, in April. The company will present longer-term follow-up data on the individualized mRNA-based candidate autogene cevumeran in patients with pancreatic...
Eagle Pharmaceuticals CFO Resigns; Shares Fall
Eagle Pharmaceuticals CFO Resigns; Shares Fall
Mar 11, 2024
02:05 PM EDT, 03/11/2024 (MT Newswires) -- Eagle Pharmaceuticals ( EGRX ) shares fell 6% in recent Monday trading after Brian Cahill resigned as chief financial officer on Friday, effective immediately. The company said in a regulatory filing that its board has instituted a search for Cahill's successor and named Steven Ratoff as interim CFO. Ratoff remains a member of...
Gatx Insider Sold Shares Worth $294,437, According to a Recent SEC Filing
Gatx Insider Sold Shares Worth $294,437, According to a Recent SEC Filing
Mar 11, 2024
02:01 PM EDT, 03/11/2024 (MT Newswires) -- Kevin Hillesland, Senior Vice President, Structured Finance, on March 08, 2024, sold 2,200 shares in Gatx ( GATX ) for $294,437. Following the Form 4 filing with the SEC, Hillesland has control over a total of 7,711 shares of the company, with 7,711 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/40211/000156218024002524/xslF345X03/primarydocument.xml Price: 132.27, Change: -0.49,...
Hypersonic weapon startup Castelion has first prototype missile test
Hypersonic weapon startup Castelion has first prototype missile test
Mar 11, 2024
WASHINGTON, March 11 (Reuters) - Castelion, a startup trying to build a hypersonic weapon for the Pentagon, tested its system for the first time, it told Reuters on Monday, as a growing group of small hypersonic arms makers challenge large defense contractors with less expensive, rapidly produced products. The United States and China are engaged in an arms race to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved